These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11345158)

  • 1. Comparative oral and topical decongestant effects of phenylpropanolamine and d-pseudoephedrine.
    Erickson CH; McLeod RL; Mingo GG; Egan RW; Pedersen OF; Hey JA
    Am J Rhinol; 2001; 15(2):83-90. PubMed ID: 11345158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in nasal resistance and nasal geometry using pressure and acoustic rhinometry in a feline model of nasal congestion.
    McLeod RL; Mingo GG; Herczku C; Corboz MR; Ramos SI; DeGennaro-Culver F; Pedersen O; Hey JA
    Am J Rhinol; 1999; 13(5):375-83. PubMed ID: 10582116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological evaluation of selective α2c-adrenergic agonists in experimental animal models of nasal congestion.
    Jia Y; Mingo GG; Hunter JC; Lieber GB; Palamanda JR; Mei H; Boyce CW; Koss MC; Yu Y; Cicmil M; Hey JA; McLeod RL
    J Pharmacol Exp Ther; 2014 Apr; 349(1):75-84. PubMed ID: 24492651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loratadine and montelukast administered in combination produce decongestion in an experimental feline model of nasal congestion.
    McLeod RL; Mingo GG; Xu X; Palamanda J; Hunter JC; Jia Y
    Am J Rhinol Allergy; 2009; 23(6):e17-22. PubMed ID: 19769798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined histamine H1 and H3 receptor blockade produces nasal decongestion in an experimental model of nasal congestion.
    McLeod RL; Mingo GG; Herczku C; DeGennaro-Culver F; Kreutner W; Egan RW; Hey JA
    Am J Rhinol; 1999; 13(5):391-9. PubMed ID: 10582118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal application of the alpha2-adrenoceptor agonist BHT-920 produces decongestion in the cat.
    Mcleod RL; Erickson CH; Mingo GG; Hey JA
    Am J Rhinol; 2001; 15(6):407-15. PubMed ID: 11777250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological characterization of a noninvasive, chronic, experimental dog model of nasal congestion.
    Koss MC; Yu Y; Hey JA; McLeod RL
    J Pharmacol Toxicol Methods; 2002; 47(1):11-7. PubMed ID: 12387934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A model of allergic nasal congestion in dogs sensitized to ragweed.
    Rudolph K; Bice DE; Hey JA; McLeod RL
    Am J Rhinol; 2003; 17(4):227-32. PubMed ID: 12962193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acoustic rhinometry in the dog: a novel large animal model for studies of nasal congestion.
    Koss MC; Yu Y; Hey JA; McLeod RL
    Am J Rhinol; 2002; 16(1):49-55. PubMed ID: 11895194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of an oral formulation of cetirizine and prolonged-release pseudoephedrine versus xylometazoline nasal spray in nasal congestion.
    Stübner UP; Toth J; Marks B; Berger UE; Burtin B; Horak F
    Arzneimittelforschung; 2001 Nov; 51(11):904-10. PubMed ID: 11765592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of the orally administered decongestants pseudoephedrine and phenylpropanolamine in children.
    Simons FE; Gu X; Watson WT; Simons KJ
    J Pediatr; 1996 Nov; 129(5):729-34. PubMed ID: 8917241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of sustained-release oral phenylpropanolamine on the nasal mucosa of healthy subjects.
    Graf P; Toll K; Palm J; Hallén H
    Acta Otolaryngol; 1999; 119(7):837-42. PubMed ID: 10687944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of an extended-release formulation of desloratadine and pseudoephedrine vs the individual components in the treatment of seasonal allergic rhinitis.
    Pleskow W; Grubbe R; Weiss S; Lutsky B
    Ann Allergy Asthma Immunol; 2005 Mar; 94(3):348-54. PubMed ID: 15801245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pseudoephedrine on nasal airflow in patients with nasal congestion associated with common cold.
    Jawad SS; Eccles R
    Rhinology; 1998 Jun; 36(2):73-6. PubMed ID: 9695162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of oral pseudoephedrine on nasal patency in the common cold: a double-blind single-dose placebo-controlled trial.
    Taverner D; Danz C; Economos D
    Clin Otolaryngol Allied Sci; 1999 Feb; 24(1):47-51. PubMed ID: 10196648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of single and multiple doses of pseudoephedrine in the treatment of nasal congestion associated with common cold.
    Eccles R; Jawad MS; Jawad SS; Angello JT; Druce HM
    Am J Rhinol; 2005; 19(1):25-31. PubMed ID: 15794071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of an oral formulation of cetirizine and prolonged-release pseudoephedrine versus budesonide nasal spray in the management of nasal congestion in allergic rhinitis.
    Zieglmayer UP; Horak F; Toth J; Marks B; Berger UE; Burtin B
    Treat Respir Med; 2005; 4(4):283-7. PubMed ID: 16086601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind, placebo-controlled trial of pseudoephedrine in coryza.
    Latte J; Taverner D; Slobodian P; Shakib S
    Clin Exp Pharmacol Physiol; 2004 Jul; 31(7):429-32. PubMed ID: 15236629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of a paracetamol-pseudoephedrine combination for treatment of nasal congestion and pain-related symptoms in upper respiratory tract infection.
    Eccles R; Jawad M; Jawad S; Ridge D; North M; Jones E; Burnett I
    Curr Med Res Opin; 2006 Dec; 22(12):2411-8. PubMed ID: 17257455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of once-daily desloratadine/pseudoephedrine for relief of nasal congestion.
    Schenkel E; Corren J; Murray JJ
    Allergy Asthma Proc; 2002; 23(5):325-30. PubMed ID: 12476542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.